# Glucocorticoids for Post-operative Patients With Acute Type A Aortic Dissection (The GLAD Trial)

Study · id `cardio:ct-nct05329740` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05329740](<https://clinicaltrials.gov/study/NCT05329740>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05329740

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 212 participants.

## Technical summary

Registry record NCT05329740. Randomized; double masking; primary purpose treatment. Start 2022-02-07 (actual); primary completion 2023-11-29 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 212 participants (enrolled count; ClinicalTrials.gov record NCT05329740, source copy `cardio:ctgov-nct05329740-2023-12-26`, retrieved 2026-11-18)
- Started: 2022-02-07 (actual) (ClinicalTrials.gov record NCT05329740, source copy `cardio:ctgov-nct05329740-2023-12-26`, retrieved 2026-11-18)
- Primary completion: 2023-11-29 (actual) (ClinicalTrials.gov record NCT05329740, source copy `cardio:ctgov-nct05329740-2023-12-26`, retrieved 2026-11-18)
- Completion: 2023-11-29 (actual) (ClinicalTrials.gov record NCT05329740, source copy `cardio:ctgov-nct05329740-2023-12-26`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT05329740, source copy `cardio:ctgov-nct05329740-2023-12-26`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05329740-2023-12-26`, retrieved 2026-11-18)

## The registry's words

- Brief title: Glucocorticoids for Post-operative Patients With Acute Type A Aortic Dissection (The GLAD Trial)
- Condition: Methylprednisolone
- Condition: Glucocorticoid
- Condition: Aortic Dissection
- Condition: Organ Dysfunction
- Intervention (Drug): Methylprednisolone Injection
- Lead sponsor: Shanghai Zhongshan Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic dissection (`cardio:aortic-dissection`)
- Registry lists this organization as the lead sponsor: Shanghai Zhongshan Hospital (`cardio:org-shanghai-zhongshan-hospital`)

## Provenance

Content hash: 48fcbee17ac456a4e9fd48f27663b24e7f23ea2b0b958cc5264f2e3c8c93d7f4
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
